SCHEMBL19786054

SCHEMBL19786054

Cc1ccc2c(c1)N(CCCN(CCCN1c3ccccc3Sc3ccc(Cl)cc31)Cc1ccccc1)c1ccccc1S2

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.65
LMNA P02545 3/20 0.65
CYP1A2 P05177 3/20 0.65
HTR1A P08908 3/20 0.65
CYP2D6 P10635 3/20 0.65
MAPT P10636 3/20 0.65
CYP2C19 P33261 3/20 0.65
SMN1; SMN2 Q16637 3/20 0.65
SIGMAR1 Q99720 3/20 0.65
DRD1 P21728 3/20 0.65
HRH1 P35367 3/20 0.65
DRD3 P35462 3/20 0.65
TDP1 Q9NUW8 2/20 0.65
SLC22A1 O15245 2/20 0.65
ABCB11 O95342 2/20 0.65
TP53 P04637 2/20 0.65
FYN P06241 2/20 0.65
CHRM2 P08172 2/20 0.65
CHRM4 P08173 2/20 0.65
CYP3A4 P08684 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19785933 0.94 DRD2 (0.70) DRD2LMNACYP1A2HTR1ACYP2D6
Chlorproethazine SCHEMBL149201 0.82 CYP1A2 (0.77) DRD2LMNACYP1A2HTR1ACYP2D6
Chlorproethazine SCHEMBL29818123 0.82 CYP1A2 (0.77) DRD2LMNACYP1A2HTR1ACYP2D6
Chlorproethazine SCHEMBL9724486 0.81 LMNA (0.78) DRD2LMNACYP1A2HTR1ACYP2D6
SCHEMBL19196333 0.80 SIGMAR1 (0.74) DRD2LMNACYP1A2HTR1ACYP2D6
SCHEMBL5880420 0.80 ITGB2 (0.73) DRD2LMNACYP1A2HTR1ACYP2D6
Chlorproethazine SCHEMBL1648952 0.80 CYP1A2 (0.74) DRD2LMNACYP1A2HTR1ACYP2D6
Chlorpromazine SCHEMBL8321 0.80 CYP1A2 (1.00) DRD2LMNACYP1A2HTR1ACYP2D6
Chlorpromazine SCHEMBL29358018 0.80 CYP1A2 (1.00) DRD2LMNACYP1A2HTR1ACYP2D6
Chlorpromazine SCHEMBL29367385 0.80 CYP1A2 (1.00) DRD2LMNACYP1A2HTR1ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018013761-A1 CALMODULIN INHIBITORS, CHK2 INHIBITORS AND RSK INHIBITORS FOR THE TREATMENT OF RIBOSOMAL DISORDERS AND RIBOSOMAPATHIES THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2018-01-18 WO disclosed